Summary: First reported case of primary central nervous system infantile fibrosarcoma. Expansion of the molecular spectrum of infantile fibrosarcoma with identification of an RBPMS::NTRK3 fusion. Marked efficacy of larotrectinib observed in an unresectable CNS tumour. Reinforces the importance of molecular testing in atypical paediatric CNS tumours.